Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma

Verfasser / Beitragende:
[G. Storto, F. Buchegger, R. Waibel, G. Kuenzi, R.E. Offord, P.A. Schubiger, M. Gillet, A.B. Delaloye]
Ort, Verlag, Jahr:
2001
Enthalten in:
Cancer Biotherapy & [and] Radiopharmaceuticals, 16/5(2001-10), 371-379
Format:
Artikel (online)
ID: 439420326